Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes
Clinical trial NCT00138554 · COMPLETED
Trial details
- NCT number
- NCT00138554
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2006-07-01
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.